UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin

Oncogene, 2003-06, Vol.22 (23), p.3616-3623

2003

Volltextzugriff (PDF)

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

The lancet oncology, 2016-10, Vol.17 (10), p.1453-1462

2016

Volltextzugriff (PDF)

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

Critical reviews in oncology/hematology, 2015-09, Vol.95 (3), p.359-369

2015

Volltextzugriff (PDF)

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Blood, 1998-06, Vol.91 (12), p.4457-4463

1998

Volltextzugriff (PDF)

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Journal of clinical oncology, 2016-12, Vol.34 (36), p.4329-4337

2016

Volltextzugriff (PDF)

Fermentation of soybean ( Glycine max) for soy- daddawa production by starter cultures of Bacillus

Food microbiology, 2002-12, Vol.19 (6), p.561-566

2002

Volltextzugriff (PDF)

Abstract PO4-20-01: A PROSPECTIVE PILOT STUDY OF MAMMOGRAPHIC PREDICTION OF WOMEN’S RISK (M-POWER) IN NIGERIA

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-20-01-PO4-20-01

2024

Volltextzugriff (PDF)

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Blood, 1998-06, Vol.91 (12), p.4457-4463

1998

Volltextzugriff (PDF)

Microbiological and biochemical changes in the traditional fermentation of soybean for ‘soy-daddawa’ — Nigerian food condiment

Food microbiology, 2000-10, Vol.17 (5), p.469-474

2000

Volltextzugriff (PDF)

Bacillus pumilus BpCRI 6, a promising candidate for cellulase production under conditions of catabolite repression

African journal of biotechnology, 2003-06, Vol.2 (6), p.140-146

2003

Volltextzugriff (PDF)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data

Current medical research and opinion, 2015-05, Vol.31 (5), p.993-1001

2015

Volltextzugriff (PDF)

Purification and characterization of cellulase from the wild-type and two improved mutants of Pseudomonas fluorescens

African journal of biotechnology, 2005-09, Vol.4 (9), p.898-904

2005

Volltextzugriff (PDF)

Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A395-A395

2013

Volltextzugriff (PDF)

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

Breast cancer research and treatment, 2011-02, Vol.126 (1), p.101-108

2011

Volltextzugriff (PDF)

Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer

Investigational new drugs, 2011-10, Vol.29 (5), p.963-970

2011

Volltextzugriff (PDF)

The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas

Current medical research and opinion, 2015-03, Vol.31 (3), p.537-545

2015

Volltextzugriff (PDF)

Regulatory mutations affecting the synthesis of cellulase in Bacillus pumilus

World journal of microbiology & biotechnology, 2002-07, Vol.18 (5), p.487-491

2002

Volltextzugriff (PDF)

PCN18 - Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A395-A395

2013

Volltextzugriff (PDF)

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Investigational new drugs, 2009-12, Vol.27 (6), p.565-570

2009

Volltextzugriff (PDF)

The molecular initiation and subsequent acquisition of disease resistance in plants

African journal of biotechnology, 2003-02, Vol.2 (2), p.26-32

2003

Volltextzugriff (PDF)

Phase I study of pemetrexed (P) and pegylated liposomal doxorubicin (PLD) in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e13515-e13515

2009

Volltextzugriff (PDF)

Gemcitabine plus paclitaxel and gemcitabine plus docetaxel in first- or second-line metastatic breast cancer: A phase II randomized trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.1046-1046

2007

Volltextzugriff (PDF)

A Phase II Trial of Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer Who Have Received Prior Taxane Therapy

Clinical breast cancer, 2010-04, Vol.10 (2), p.148-153

2010

Volltextzugriff (PDF)

Regulatory mutations affecting the synthesis of cellulase in Pseudomonas fluorescens

African journal of biotechnology, 2005-08, Vol.4 (8), p.838-843

2005

Volltextzugriff (PDF)

A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1095-1095

2008

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Humans
(12)
Biological And Medical Sciences
(8)
Oncology
(8)
Female
(7)
Biotechnology & Applied Microbiology
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Middle Aged
(6)
Adult
(5)
Aged
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Microbiology
(5)
Treatment Outcome
(5)
Breast Neoplasms - Drug Therapy
(4)
Cancer Therapies
(4)
Clinical Trials
(4)
Male
(4)
Medicine
(4)
Mutants
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Fermentation of soybean ( Glycine max) for soy- daddawa production by starter cultures of Bacillus

Abstract PO4-20-01: A PROSPECTIVE PILOT STUDY OF MAMMOGRAPHIC PREDICTION OF WOMEN’S RISK (M-POWER) IN NIGERIA

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Microbiological and biochemical changes in the traditional fermentation of soybean for ‘soy-daddawa’ — Nigerian food condiment

Bacillus pumilus BpCRI 6, a promising candidate for cellulase production under conditions of catabolite repression

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data

Purification and characterization of cellulase from the wild-type and two improved mutants of Pseudomonas fluorescens

Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic Review

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer

The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas

Regulatory mutations affecting the synthesis of cellulase in Bacillus pumilus

PCN18 - Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic Review

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

The molecular initiation and subsequent acquisition of disease resistance in plants

Phase I study of pemetrexed (P) and pegylated liposomal doxorubicin (PLD) in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer

Gemcitabine plus paclitaxel and gemcitabine plus docetaxel in first- or second-line metastatic breast cancer: A phase II randomized trial

A Phase II Trial of Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer Who Have Received Prior Taxane Therapy

Regulatory mutations affecting the synthesis of cellulase in Pseudomonas fluorescens

A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results

Suchergebnisse filtern